Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,511
Closed -$363K 168
2024
Q1
$363K Buy
9,511
+84
+0.9% +$3.17K 0.05% 119
2023
Q4
$356K Buy
9,427
+1,017
+12% +$34.1K 0.06% 118
2023
Q3
$286K Buy
8,410
+299
+4% +$11.3K 0.05% 123
2023
Q2
$319K Buy
8,111
+142
+2% +$5.13K 0.06% 126
2023
Q1
$256K Hold
7,969
0.05% 131
2022
Q4
$250K Sell
7,969
-63
-0.8% -$2.28K 0.05% 135
2022
Q3
$353K Buy
+8,032
New +$301K 0.07% 122
2021
Q4
Sell
-38,194
Closed -$2.4M 158
2021
Q3
$2.4M Buy
38,194
+839
+2% +$46.3K 0.37% 43
2021
Q2
$1.8M Buy
37,355
+13,900
+59% +$781K 0.29% 51
2021
Q1
$1.2M Buy
+23,455
New +$1.1M 0.21% 72

Other funds holding PGNY

CIM LLC's PGNY Position: Q2 2024 in Review

CIM LLC sold out of Progyny (PGNY) in Q2 2024, closing a stake of 9,511 shares — an estimated $363K sold.

CIM LLC first reported a position in PGNY in Q1 2021 and held it in 10 quarters. The position peaked at $2.4M in Q3 2021. 324 funds tracked by Wall St. Rank hold PGNY as of Q2 2024.

  • CIM LLC reported no remaining Progyny position as of Q2 2024 after selling out during the quarter.
  • CIM LLC sold 9,511 Progyny shares in Q2 2024, an estimated $363K.
  • CIM LLC first reported a position in Progyny in Q1 2021 and held it in 10 quarters.
  • CIM LLC's Progyny position peaked at $2.4M in Q3 2021.
  • 324 funds tracked by Wall St. Rank held Progyny as of Q2 2024.

Based on CIM LLC's 13F filing for Q2 2024, filed 6 Sep 2024.